Be a Smart Investor
Thursday, April 28, 2016
AbbVie to buy Stemcentrx in $5.8 billion deal
Drugmaker AbbVie said it would buy privately held oncology company Stemcentrx in a deal valued at $5.8 billion in cash and stock.
from Mergers and Acquisitions http://ift.tt/2391HJ8
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment